Pre-Existing Interstitial Lung Abnormalities Are Independent Risk Factors for Interstitial Lung Disease during Durvalumab Treatment after Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer

SIMPLE SUMMARY: Interstitial lung disease (ILD) is a life-threatening toxicity caused by chemoradiotherapy and durvalumab; however, the risk factors for ILD during durvalumab treatment after chemoradiotherapy have not been established in non-small-cell lung cancer patients. We examined whether inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Daido, Wakako, Masuda, Takeshi, Imano, Nobuki, Matsumoto, Naoko, Hamai, Kosuke, Iwamoto, Yasuo, Takayama, Yusuke, Ueno, Sayaka, Sumii, Masahiko, Shoda, Hiroyasu, Ishikawa, Nobuhisa, Yamasaki, Masahiro, Nishimura, Yoshifumi, Kawase, Shigeo, Shiota, Naoki, Awaya, Yoshikazu, Suzuki, Tomoko, Kitaguchi, Soichi, Fujitaka, Kazunori, Nagata, Yasushi, Hattori, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776853/
https://www.ncbi.nlm.nih.gov/pubmed/36551721
http://dx.doi.org/10.3390/cancers14246236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776853/
https://www.ncbi.nlm.nih.gov/pubmed/36551721
http://dx.doi.org/10.3390/cancers14246236

Ejemplares similares